BMY vs LLY
Bristol-Myers Squibb and Eli Lilly side by side, scored on the same KC Score model. LLY currently has the higher KC Score. Descriptive data only — not a recommendation.
BMY
Bristol-Myers Squibb
Firm trend — momentum and price structure are constructive.
Price$62.86
3-month+7.3%
6-month+7.4%
52-week range78%
Volatility28%
LLY
Eli Lilly
Strong, established uptrend with positive momentum.
Price$1,183.46
3-month-3.8%
6-month+34.8%
52-week range81%
Volatility36%
Take it further
TradingView
Pro-grade charts, indicators, screeners and price alerts. Free plan available.
Popular UK investing platforms
Commission-free ISAs & general accounts. Not a recommendation — compare fees and features yourself.
Trading 212
Commission-free ISA & GIA investing. Free fractional share on signup.
Open account →
InvestEngine
Low-cost ETF portfolios and ISAs. Welcome bonus for new accounts.
Open account →
Freetrade
Commission-free UK & US shares in an ISA. Free share on signup.
Open account →
Some links are affiliate links — we may earn a commission at no extra cost to you. This never affects our analysis.
Ad space
Popular comparisons
Know how you actually invest
What kind of investor are you?
AlphaScore reads your real trade history and names your investor type — your edge, your blind spots, your next moves. Your statement never leaves your device. Free.